Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648620 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon
A NA study, sponsored by SurModics.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02648620 is a NA study that has completed, run by SurModics. The registered enrollment target is 13 participants.
The verdict
NCT02648620, a NA study, has completed, sponsored by SurModics.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
PREVEIL is a prospective, multi-center, single-arm clinical trial to assess the safety and functionality of the SurModics drug coated balloon (DCB) in the treatment of subjects with symptomatic peripheral artery disease (PAD) due to de novo stenoses of the femoral and popliteal arteries. The trial will enroll up to 15 subjects.
Interventions
- PROCEDURE Angioplasty
- DEVICE SurVeil Drug Coated Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-04-05 |
| Est. Completion | 2020-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02648620
The ClinicalTrials.gov registry entry for NCT02648620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SurModics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Angioplasty is the first listed.
NCT02648620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02648620 about?
NCT02648620 is a clinical study titled "Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon". PREVEIL is a prospective, multi-center, single-arm clinical trial to assess the safety and functionality of the SurModics drug coated balloon (DCB) in the treatment of subjects with symptomatic peripheral artery disease (PAD) due to de novo stenoses of the femoral and popliteal arteries. The trial w...
What is the current status of trial NCT02648620?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-04-05. Estimated completion is 2020-02-11.
What interventions are being tested in trial NCT02648620?
The interventions under investigation include: Angioplasty (PROCEDURE), SurVeil Drug Coated Balloon (DEVICE).
Who is sponsoring clinical trial NCT02648620?
This trial is sponsored by SurModics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.